World-Class
Injectable Solutions
for Global Healthcare

Trusted by Global Regulatory Authorities

Delivering excellence
in sterile injectable manufacturing for a healthier tomorrow

Welcome to Abryl, a leading-edge pharmaceutical manufacturing facility specializing in high-quality liquid and freeze-dried sterile injectable products, including pre-filled syringes. With advanced technology and infrastructure designed to meet the most rigorous global standards, we ensure the highest levels of safety, consistency, and reliability. Integrity and excellence are at the core of our operations, making Abryl a trusted partner in the healthcare industry.
Manufacturing

Explore Our Advanced Product Offerings

Discover our range of sterile solutions designed for precision and safety. Each product is crafted with cutting-edge technology to meet the highest standards.

production-&-packing

Production

Designed in accordance with the latest regulatory requirements, the Production Department complies fully with USFDA and EU-GMP guidelines.

microbiology

Microbiology

A state-of-the-art microbiology lab is in place. The microbiology lab houses all required instruments and equipment as per to prepare & incubate media and isolate microorganisms.

quality-control

Quality Control

A fully equipped QC lab with precise and accurate instruments is provided in the manufacturing block. All practices are carried out as per GLP.

Research & Development

Abryl’s Research & Development department (R&D) is focused towards developing new products, improving existing products, drug delivery systems, and expanding product applications. The team is focussed on overcoming and resolving complex chemical challenges. The In-house R&D forms the backbone of our operations.

Situated within the plant campus, the block is completely segregated from the manufacturing block. The state-of-the art laboratory is provided with dedicated formulation and analytical labs.

Lyophilizer

HPLC Systems

GC System

vial

Vial Manufacturing Capabilities

Abryl Laboratories' high-speed two-vial manufacturing lines are engineered for the efficient, large-scale production of sterile injectable products in vial presentations. Designed to support both liquid and lyophilized formulations, the lines feature advanced automation for vial washing, sterilization, filling, stoppering, and sealing, ensuring minimal human intervention and optimal aseptic control. With robust throughput capacity, the lines can process a high volume of vials per hour while maintaining precision, consistency, and compliance with cGMP and international regulatory standards. Integrated in-line inspection systems and environmental monitoring further support product integrity and operational reliability, making these lines ideal for commercial-scale manufacturing and contract manufacturing services. The facility is equipped to manufacture sterile injectable products in vial sizes ranging from 1 mL to 100 mL, offering flexibility to meet diverse product specifications and customer requirements across both liquid and lyophilized formulations.

Ampoule Manufacturing Capabilities

Abryl Laboratories' high-speed ampoule manufacturing line is designed for the precision
filling and sealing of sterile liquid injectables at commercial scale. Equipped with advanced automation and servo-controlled systems, the line ensures high-speed processing with exceptional accuracy and minimal product loss. The integrated operations include ampoule feeding, washing, sterilization, precise liquid filling, tip sealing, and 100% in-line visual inspection. Engineered for optimal aseptic performance, the line supports continuous, high- volume production while maintaining strict compliance with cGMP and international regulatory standards. This fully automated system ensures consistent quality, enhanced sterility assurance, and operational efficiency. The manufacturing line is equipped to produce sterile injectable products in ampoule sizes ranging from 1 mL to 25 mL, offering the flexibility to meet diverse product specifications and customer requirements.

ampoule
pfs

PFS Manufacturing Capabilities

Abryl Laboratories utilizes a specialized pre-filled syringe (PFS) manufacturing line designed exclusively for the aseptic handling and filling of pre-sterilized syringes. This advanced machine streamlines the filling process by integrating automated syringe loading, precision filling, stopper placement, and sealing within a fully controlled sterile environment. Equipped with high-accuracy dosing systems and in-line quality inspection, the line ensures product integrity, dose uniformity, and contamination prevention. Engineered to meet stringent cGMP and international regulatory requirements, the system supports efficient commercial-scale production while maintaining the highest standards of sterility and operational reliability. This dedicated pre-filled syringe line enables the safe and efficient manufacture of ready-to-use injectable therapies, supporting global pharmaceutical partners in delivering innovative, patient-centric solutions. Abryl Laboratories has the capability to manufacture pre-filled syringes with fill volumes ranging from 0.25 mL to 10 mL, offering flexibility to meet diverse product specifications and customer requirements.

Freeze Drying Technology

Abryl Laboratories houses large-scale lyophilizers, purpose-built for high-volume freeze-drying of sterile injectable products in vials. These advanced systems provide precise control over critical parameters such as shelf temperature, chamber pressure, and drying time, ensuring optimal product stability and consistency across batches. Integrated within a Grade A aseptic environment, both lyophilizers are supported by a dedicated automatic capping machine, which securely seals vials immediately after lyophilization to maintain sterility and product integrity. The entire process is automated and compliant with cGMP and global regulatory standards, enabling efficient commercial-scale production of lyophilized injectables with robust quality assurance. Abryl Laboratories has the capability to perform freeze-drying of sterile injectable products in vial sizes ranging from 1 mL to 100 mL, offering flexibility to accommodate diverse product specifications and manufacturing requirements.

freeze-drying-technology
doctor-performing-medical-research-lab

Nanomilling Manufacturing

Abryl Laboratories leverages advanced Netzsch wet nano-milling technology, utilizing equipment such as the DeltaVita® and Zeta® RS mills, to produce high-quality nanosuspensions for sterile injectable formulations. These state-of-the-art systems employ high-energy bead milling with exceptionally fine grinding media (30–300 µm), allowing precise particle size reduction into the 100–300 nm range, significantly enhancing API solubility, bioavailability, and stability. The mills operate under fully enclosed, sterile conditions and include features like in-line particle size monitoring, CIP/SIP capability, and robust control of temperature and flow, ensuring process validation, repeatability, and full compliance with cGMP. With scalable configurations—from small laboratory units to large production-scale systems—Abryl can seamlessly transition formulations from R&D to commercial manufacture while maintaining critical quality attributes ascendiacdmo.com. Ideal for parenteral nanosuspensions, injectable emulsions, or advanced drug delivery platforms, our Netzsch nano milling capability underpins the development of next-generation sterile injectables with superior therapeutic performance.